Latest News & Features
Americas
Japan-based Otsuka Pharmaceuticals has filed a complaint against US-based Zydus Pharmaceuticals for allegedly infringing a patent directed to the drug Abilify. 26 October 2016
Americas
Irish pharmaceutical company Adapt Pharma has filed a complaint against Teva for allegedly infringing a patent centring on its nasal spray Narcan. 25 October 2016
Americas
Two bodies are responsible for examining biotech patent applications in Brazil, but this approach causes problems, as Marcelo Oliveira de Souza and Antonio Alexandre Moura dos Santos of Di Blasi, Parente & Associados report. 25 October 2016
Americas
Japanese drug company Astellas has filed a complaint against Canada-based Apotex for allegedly infringing its patents centring on the drug Myrbetriq. 24 October 2016
Americas
The US Court of Appeals for the Federal Circuit yesterday rejected Medtronic’s petition for a rehearing of a patent case against Bosch. 21 October 2016
Americas
The ‘promise doctrine’ has had, and will probably continue to have, a damaging impact on Canada’s investment portfolio, a report has said. 21 October 2016
Africa
Healthcare company Novartis has won a domain name dispute at the World Intellectual Property Organization Arbitration and Mediation Center. 20 October 2016
Big Pharma
European law firm Fieldfisher has strengthened its intellectual property expertise with the appointment of three team members in Milan, Italy. 20 October 2016
Americas
The US Food and Drug Administration has awarded 21 new clinical trial research grants totalling more than $23 million in order to boost the development of products for patients with rare diseases. 20 October 2016
Europe
The UK’s vote to leave the EU may allow Britain to replace the SPC regulation—an often-criticised piece of law—and take a fresh approach to the system governing these rights, say Paul England and Matthew Royle of Taylor Wessing. 20 October 2016